Suven Pharmaceuticals enters into agreement with CSIR:

Suven Pharmaceuticals

Suven Pharmaceuticals and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram have entered into an agreement for the process technology transfer and manufacturing of the anti COVID drug, Molnupiravir and 2-DG.

Suven Pharmaceuticals was quoting at Rs 489.55, up Rs 8.70, or 1.81 percent on the BSE.

News Source:- Moneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button